There are differences in the secretion levels of immune factors and inflammatory factors in patients with different immune classifications, but patients can still find the same markers to evaluate the prognosis; for example, Dong Yi et al. have found that the expression of p53 protein, bcl-2 protein, and soluble interleukin-2 receptor (sIL-2R) in patients with MM at the first diagnosis and subsequent visit is positively correlated with β2-microglobulin (β2-MG), speculating that p53 protein, bcl-2 protein, and sIL-2R can be used to predict the recurrence of MM [7]. This evidence concerns the gene HLA-G and Miyoshi myopathy.